The Patent Finder

MT. Cook Pharma, Inc.

Also on record
Records under this name other than patents MT. Cook Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to MT. Cook Pharma, Inc.

PatentTitleStatus Expires Confidence
US 8,642,599Method of Treating Parkinson's Disease with Diarylmethylpiperazine Compounds Exhibiting Delta Receptor Agonist Activity
Formerly held
Lapsed on the fee record
Ended Feb 4, 2026 · High confidence
Lapsed on the fee recordEnded Feb 4, 2026High confidence
US 6,924,288Enantiomerically pure opioid diarylmethylpiperzine and methods of using same
Formerly held
Term ended
Term ended May 1, 2023 · From the USPTO record
Term endedTerm ended May 1, 2023From the USPTO record
US 7,189,725Enantiomerically pure opioid diarylmethylpiperazine as a cardioprotection agent
Formerly held
Term ended
Term ended Oct 8, 2022 · From the USPTO record
Term endedTerm ended Oct 8, 2022From the USPTO record
US 7,683,168Compositions of novel opioid compounds and method of use thereof
Formerly held
Lapsed on the fee record
Ended Mar 23, 2022 · From the USPTO record
Lapsed on the fee recordEnded Mar 23, 2022From the USPTO record
US 8,575,169Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
Formerly held
Lapsed on the fee record
Ended Nov 5, 2021 · From the USPTO record
Lapsed on the fee recordEnded Nov 5, 2021From the USPTO record
US 8,476,280Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
Formerly held
Lapsed on the fee record
Ended Jul 2, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jul 2, 2021From the USPTO record
US 7,314,880Cardioprotective delta opioid receptor agonists and methods of using same
Formerly held
Lapsed on the fee record
Ended Jan 1, 2020 · From the USPTO record
Lapsed on the fee recordEnded Jan 1, 2020From the USPTO record
US 6,630,515Urinary incontinence therapy
Formerly held
Term ended
Term ended Aug 21, 2018 · From the USPTO record
Term endedTerm ended Aug 21, 2018From the USPTO record
US 7,030,124Method of treating depression with delta receptor agonist compounds
Formerly held
Lapsed on the fee record
Ended Apr 18, 2018 · From the USPTO record
Lapsed on the fee recordEnded Apr 18, 2018From the USPTO record
US 6,300,332Methods for reducing respiratory depression and attendant side effects of mu opioid compounds
Formerly held
Lapsed on the fee record
Ended Oct 9, 2009 · From the USPTO record
Lapsed on the fee recordEnded Oct 9, 2009From the USPTO record
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited